Efficacy and toxicity comparison of nab-paclitaxel plus S-1 and nab-paclitaxel plus gemcitabine as first-line chemotherapy for metastatic pancreatic cancer

Efficacy and toxicity comparison of nab-paclitaxel plus S-1 and nab-paclitaxel plus gemcitabine as first-line chemotherapy for metastatic pancreatic cancer

Abstract. To compare efficacy and safety of nab-paclitaxel plus gemcitabine (AG) with nab-paclitaxel plus S-1 (AS) as first-line treatment for metastatic pancreatic cancer, we conducted a retrospective analysis by reviewing medical records of 53 metastatic pancreatic cancer patients in our instituti...

Full description

Bibliographic Details
Main Authors: Xi Guo, MD, Yaolin Xu, MD, Yuan Ji, MD, Yue Fan, MD, Dansong Wang, MD, Dayong Jin, MD, Rongyuan Zhuang, MD, Lili Wu, MD, Wenhui Lou, MD, Yuhong Zhou, MD
Format: Article
Language:English
Published: Wolters Kluwer Health/LWW 2020-03-01
Series:Journal of Pancreatology
Online Access:http://journals.lww.com/10.1097/JP9.0000000000000038

Internet

http://journals.lww.com/10.1097/JP9.0000000000000038

Similar Items